Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPG Block for Emergence Agitation in Nasal Surgery
NCT04168879Completed
- Sponsor
- Assiut University
- Start
- Nov 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in Emergence agitation (EA) (2 arms), sponsored by Assiut University. Primary endpoint: Postoperative emergence agitation at 2 hours. Started Nov 2021; status: completed.
02
Drugs
bupivacaine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT04168879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04168879.